在侵袭性益生菌瘤中体质激活ESR1突变
Ticiana Paes1, Jacobo Buelvas Mebarak1, John C Magnotto1
1Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
The Journal of clinical endocrinology and metabolism
|September 6, 2024
概括
一个特定的基因突变,ESR1Y537S,被发现在一个积极的益生菌瘤. 这种雌激素受体信号通路的发现导致了以elacestrant成功的向治疗,控制了瘤生长和降低了前素水平.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 甲状腺瘤,分泌甲状腺素的垂体瘤,有一个鲜为人知的遗传基础.
- 雌激素受体信号传递与各种癌症有关,但其在益生菌瘤中的作用尚不清楚.
研究的目的:
- 为了识别前乳腺瘤的体质遗传变化.
- 为了研究雌激素受体α (ESR1) 突变在侵袭性益生菌瘤中的作用.
主要方法:
- 大规模并行测序 (OncoPanel) 用于分析益生菌瘤的遗传特征.
- 在20名患者的队列中评估了体质突变和拷贝数变异.
主要成果:
- 一个激进的益生菌瘤中发现了一种激活ESR1Y537S突变.
- 这种益生菌瘤表现出大量的副本数变异 (233个事件).
- 用elacestrant和放射治疗治疗控制了瘤生长,并降低了ESR1突变患者的益生菌水平.
结论:
- 这种ESR1Y537S突变可能导致益生菌瘤的攻击性.
- 雌激素受体信号传递对益生菌瘤的发展和进展具有重要意义.
- 使用elacestrant的向治疗为具有ESR1突变的侵袭性益生菌瘤提供了潜在的治疗策略.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
